CANC vs SPYM5YCANCCANCAvsBSPYMSPYMTema Oncology ETF · $211MState Street SPDR Portfolio S&P 500 ETF · $186BReturns · dividends in+22.8%3 years · per year$18,519 · $17,273+20.0%[…]5 years · per year[…] · $16,811+10.9%Cost and income0.99%Expense ratio$99 · $2 on $10k · lower wins0.02%0.05%12-mo yield$5 · $106 on $10k1.06%
Overlap: CANC, SPYM, VTIToday87.9%most shared, SPYM and VTICANCSPYMVTICANC—5.1%4.9%SPYM5.1%—87.9%VTI4.9%87.9%—End-of-day Nov 17, 2026 · share held in common · outlined: the pair in versus
CANC vs SPYM5YACANCTema Oncology[…]vsSPYMBSPDR Portfolio S&P 500$16,811MeasureCANCSPYMFee0.99%0.02%Cost on $10k a year$99$2Yield0.05%1.06%5 years, per year[…]+10.9%3 years, per year+22.8%+20.0%Worst drop · 1Y−13.2%−8.9%Volatility · 1Y24.2%13.8%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BSPYMState Street SPDR Portfolio S&P 500 ETFReadDesk0.02%1.06%−1.0%+8.3%+10.2%+20.0%+10.9%−8.9%$185.8B2VTIVanguard Morningstar Total Stock Market ETFReadDesk0.03%1.10%−1.1%+8.4%+10.4%+19.8%+9.8%−8.9%$689.3B3ACANCTema Oncology ETFReadDesk0.99%0.05%−1.8%+13.8%+19.1%+22.8%new−13.2%$211MEnd-of-day Nov 17, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BSPYMState Street SPDR Portfolio S&P 500 ETFReadDesk0.02%1.06%−1.0%+8.3%+10.2%+20.0%+10.9%−8.9%$185.8B2VTIVanguard Morningstar Total Stock Market ETFReadDesk0.03%1.10%−1.1%+8.4%+10.4%+19.8%+9.8%−8.9%$689.3B3ACANCTema Oncology ETFReadDesk0.99%0.05%−1.8%+13.8%+19.1%+22.8%new−13.2%$211MEnd-of-day Nov 17, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
SPYM vs SPYYTDSPDRSPYMSA+8.3%vsBSSPYSPDR+8.2%Jan 1Nov 17+8.3%+8.2%+8.3%Year to date+8.2%1.1%Yield1.0%$186BAssets$807B2–0SPYM winsEnd-of-day Nov 17, 2026
VTI vs ITOTYTDVanguardVTIVA+8.4%vsBiSITOTiShares+8.2%Jan 1Nov 17+8.4%+8.2%+8.4%Year to date+8.2%1.1%Yield1.1%$689BAssets$94.1B1–0VTI winsEnd-of-day Nov 17, 2026
SCHD vs VIGYTDSchwabSCHDSA+31.9%vsBVVIGVanguard+13.4%Jan 1Nov 17+31.9%+13.4%+31.9%Year to date+13.4%3.0%Yield1.5%$124BAssets$116B2–0SCHD winsEnd-of-day Nov 17, 2026
Overlap: CANC, SPYM, VTIToday87.9%most shared, SPYM and VTICANCSPYMVTICANC—5.1%4.9%SPYM5.1%—87.9%VTI4.9%87.9%—End-of-day Nov 17, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$107most kept, VTIVTI$110 − $3 = $107SPYM$106 − $2 = $104CANC$5 − $99 = −$94KeptFeeEnd-of-day Nov 17, 2026 · yield in dollars minus the fee